Fabien Huet

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Cardiovascular Disease

Acute Heart Failure

Acute Myocardial Infarction

Top Venues

Pharmaceuticals (Basel, Switzerland)

Future science OA

Journal of clinical medicine

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Quentin Delbaere, Nicolas Chapet, Fabien Huet, Clément Delmas, Nathan Mewton, Fabrice Prunier, Denis Angoulvant, Francois Roubille
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Laura Sofia Cardelli, Miloud Cherbi, Fabien Huet, Guillaume Schurtz, Eric Bonnefoy-Cudraz, Edouard Gerbaud, Laurent Bonello, Guillaume Leurent, Etienne Puymirat, Gianni Casella, Clément Delmas, Francois Roubille
Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Quentin Delbaere, Nicolas Chapet, Fabien Huet, Clément Delmas, Nathan Mewton, Fabrice Prunier, Denis Angoulvant, Francois Roubille
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Quentin Delbaere, Nicolas Chapet, Fabien Huet, Clément Delmas, Nathan Mewton, Fabrice Prunier, Denis Angoulvant, Francois Roubille
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Laura Sofia Cardelli, Miloud Cherbi, Fabien Huet, Guillaume Schurtz, Eric Bonnefoy-Cudraz, Edouard Gerbaud, Laurent Bonello, Guillaume Leurent, Etienne Puymirat, Gianni Casella, Clément Delmas, Francois Roubille
Beta Blockers Improve Prognosis When Used Early in Patients with Cardiogenic Shock: An Analysis of the FRENSHOCK Multicenter Prospective Registry. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Quentin Delbaere, Nicolas Chapet, Fabien Huet, Clément Delmas, Nathan Mewton, Fabrice Prunier, Denis Angoulvant, Francois Roubille
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Jean-Etienne Ricci, Sylvain Aguilhon, Bob-Valéry Occean, Camille Soullier, Kamila Solecki, Christelle Robert, Fabien Huet, Luc Cornillet, Laurent Schmutz, Thierry Chevallier, Mariama Akodad, Florence Leclercq, Guillaume Cayla, Benoit Lattuca, Francois Roubille
Impact of Daily Bedside Echocardiographic Assessment on Readmissions in Acute Heart Failure: A Randomized Clinical Trial. Journal of clinical medicine 11 (7) (2022)
Eran Kalmanovich, Pascal Battistella, Philippe Rouviere, Bernard Albat, Jean-Marc Frapier, Roland Demaria, Fabien Huet, Audrey Agullo, Marc Mourad, Pascal Colson, Florence Leclercq, Philippe Gaudard, Francois Roubille
Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients. Future science OA 7 (4) (2021)
Fabien Huet, Anne-Marie Dupuy, Claire Duflos, Cintia Azara Reis, Nils Kuster, Sylvain Aguilhon, Jean-Paul Cristol, Francois Roubille
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry. Future science OA 7 (5) (2021)
Fabien Huet, Quentin Delbaere, Sylvain Aguilhon, Valentin Dupasquier, Delphine Delseny, Richard Gervasoni, Jean-Christophe Macia, Florence Leclercq, Nidal Jammoul, Sandra Kahlouche, Sonia Soltani, Fanny Cardon, Anne Marie Dupuy, Jean-Paul Cristol, Denis Mariano-Goulart, Mariama Akodad, Nicolas Nagot, François Roubille
Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol. Medicina (Kaunas, Lithuania) 57 (10) (2021)
Fabien Huet, Jérémy Fauconnier, Marion Legall, Pierre Sicard, Catherine Lozza, Alain Lacampagne, François Roubille
Low-dose colchicine prevents sympathetic denervation after myocardial ischemia-reperfusion: a new potential protective mechanism. Future science OA 7 (2) (2020)